AngioDynamics (ANGO) Director Reed Jan Stern Receives Award

What Happened Reed Jan Stern, a director of AngioDynamics, was granted 11,887 restricted stock units (RSUs) on July 15, 2026 as regular annual compensation. The award was reported on a Form 4 filed July 22, 2026. The RSUs have a reported acquisition price of $0.00 (award), aggregate reported value $0. Per the filing footnote, the RSUs vested immediately at grant.

Key Details

• Transaction type: Award/Grant (Code A) — 11,887 RSUs
• Transaction date: 2026-07-15; Form 4 filed: 2026-07-22 (filed after the usual 2-business-day window)
• Price: $0.00 per share; aggregate value shown as $0 (compensation award)
• Vesting: Immediately vested at grant (per footnote)
• Shares owned after transaction: Not specified in the provided filing excerpt
• Note: This was granted as regular annual director compensation (footnote provided)

Context Grants of RSUs are compensation, not open-market purchases or sales; immediate vesting means the director now owns the shares outright (subject to company trading policies and any holding requirements). Such awards are routine for non-employee directors and do not necessarily signal a change in insider sentiment. The Form 4 was filed about seven days after the transaction date, which is later than the typical 2-business-day reporting window and may draw administrative scrutiny.